Manas Petroleum Corporation Announces Grants and Cancellations of Stock Options and Amendment to the Consulting Agreement with Investor Relations Consultant
BAAR, Switzerland, Feb. 28, 2013 /PRNewswire/ -- Manas Petroleum Corporation ("Manas" or the"Company") (TSX‑V: MNP; OTCBB:MNAP) announces that effective as of February 1, 2013, the Company granted 1,000,000 stock options to each of Murray Rodgers and Darcy Spady, two of the Company's directors, for an aggregate of 2,000,000 stock options. Each stock option isexercisable at a price of CDN$0.15 per share for a period of 10 years and vesting in 2 years in quarterly installments. The grant is subject to the execution of stock option agreements by Messrs. Rodgers and Spady and the terms of the Company's 2011 stock option plan.
Effective as of February 1, 2013, the Company also granted 750,000 stock options to General Research GmbH ("General Research"). Each stock option is exercisable at a price of CDN$0.15 per share for a period of 5 years and vesting in 2 years in quarterly installments. The grant is subject to the execution of a stock option agreement by General Research and the terms of the Company's 2011 stock option plan.
Some of the Company's directors and officers have agreed to cancel an aggregate of 4,850,000 stock options to allow the Company to grant stock options to others. Currently, the Company's stock option plan allows the Company to grant stock options to acquire up to a maximum of 10% of the number of issued and outstanding shares of the Company's common stock at the time of the grant.
Effective as of February 1, 2013, the Company entered into an amendment to the consulting agreement with General Research, the Company's investor relations consultant, whereby the Company and General Research amended the consulting agreement effective as of November 22, 2011 to provide that on an "as-needed" and "as-requested" basis, General Research will provide market-making services relating to the Company's securities in accordance with the applicable securities laws and policies of the TSX Venture Exchange.
Effective as of February 1, 2013, the Company also granted 750,000 stock options to General Research GmbH ("General Research"). Each stock option is exercisable at a price of CDN$0.15 per share for a period of 5 years and vesting in 2 years in quarterly installments. The grant is subject to the execution of a stock option agreement by General Research and the terms of the Company's 2011 stock option plan.
Some of the Company's directors and officers have agreed to cancel an aggregate of 4,850,000 stock options to allow the Company to grant stock options to others. Currently, the Company's stock option plan allows the Company to grant stock options to acquire up to a maximum of 10% of the number of issued and outstanding shares of the Company's common stock at the time of the grant.
Effective as of February 1, 2013, the Company entered into an amendment to the consulting agreement with General Research, the Company's investor relations consultant, whereby the Company and General Research amended the consulting agreement effective as of November 22, 2011 to provide that on an "as-needed" and "as-requested" basis, General Research will provide market-making services relating to the Company's securities in accordance with the applicable securities laws and policies of the TSX Venture Exchange.
Comments
Post a Comment